This influx is mainly related to the inhibition of tumor overexpression of IDO by imatinib, since a decrease in IDO1 mRNA (independent of the decrease in the number of tumor cells) was mainly observed, leading to a depletion of intratumoral regulatory T cells and thus an increase in the CD8/Treg ratio. The gene discussed is CD8A; the disease is neoplasm.